<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>The 'escalation' package. — escalation-package • escalation</title><!-- favicons --><link rel="icon" type="image/png" sizes="96x96" href="../favicon-96x96.png"><link rel="icon" type="”image/svg+xml”" href="../favicon.svg"><link rel="apple-touch-icon" sizes="180x180" href="../apple-touch-icon.png"><link rel="icon" sizes="any" href="../favicon.ico"><link rel="manifest" href="../site.webmanifest"><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><link href="../deps/font-awesome-6.5.2/css/all.min.css" rel="stylesheet"><link href="../deps/font-awesome-6.5.2/css/v4-shims.min.css" rel="stylesheet"><script src="../deps/headroom-0.11.0/headroom.min.js"></script><script src="../deps/headroom-0.11.0/jQuery.headroom.min.js"></script><script src="../deps/bootstrap-toc-1.0.1/bootstrap-toc.min.js"></script><script src="../deps/clipboard.js-2.0.11/clipboard.min.js"></script><script src="../deps/search-1.0.0/autocomplete.jquery.min.js"></script><script src="../deps/search-1.0.0/fuse.min.js"></script><script src="../deps/search-1.0.0/mark.min.js"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="The 'escalation' package. — escalation-package"><meta name="description" content="escalation provides methods for working with dose-finding clinical trials.
We provide implementations of many dose-finding clinical trial designs,
ncluding the continual reassessment method (CRM) by O'Quigley et al. (1990)
&amp;lt;doi:10.2307/2531628&amp;gt;, the toxicity probability interval (TPI) design by Ji
et al. (2007) &amp;lt;doi:10.1177/1740774507079442&amp;gt;, the modified TPI (mTPI) design
by Ji et al. (2010) &amp;lt;doi:10.1177/1740774510382799&amp;gt;, the Bayesian optimal
interval design (BOIN) by Liu &amp;amp; Yuan (2015) &amp;lt;doi:10.1111/rssc.12089&amp;gt;, EffTox
by Thall &amp;amp; Cook (2004) &amp;lt;doi:10.1111/j.0006-341X.2004.00218.x&amp;gt;; the design of
Wages &amp;amp; Tait (2015) &amp;lt;doi:10.1080/10543406.2014.920873&amp;gt;, and the 3+3
described by Korn et al. (1994) &amp;lt;doi:10.1002/sim.4780131802&amp;gt;. All designs
are implemented with a common interface. We also offer optional additional
classes to tailor the behaviour of all designs, including avoiding skipping
doses, stopping after n patients have been treated at the recommended dose,
stopping when a toxicity condition is met, or demanding that n patients are
treated before stopping is allowed. By daisy-chaining together these classes
using the pipe operator from 'magrittr', it is simple to tailor the
behaviour of a dose-finding design so it behaves how the trialist wants.
Having provided a flexible interface for specifying designs, we then provide
functions to run simulations and calculate dose-paths for future cohorts of
patients."><meta property="og:description" content="escalation provides methods for working with dose-finding clinical trials.
We provide implementations of many dose-finding clinical trial designs,
ncluding the continual reassessment method (CRM) by O'Quigley et al. (1990)
&amp;lt;doi:10.2307/2531628&amp;gt;, the toxicity probability interval (TPI) design by Ji
et al. (2007) &amp;lt;doi:10.1177/1740774507079442&amp;gt;, the modified TPI (mTPI) design
by Ji et al. (2010) &amp;lt;doi:10.1177/1740774510382799&amp;gt;, the Bayesian optimal
interval design (BOIN) by Liu &amp;amp; Yuan (2015) &amp;lt;doi:10.1111/rssc.12089&amp;gt;, EffTox
by Thall &amp;amp; Cook (2004) &amp;lt;doi:10.1111/j.0006-341X.2004.00218.x&amp;gt;; the design of
Wages &amp;amp; Tait (2015) &amp;lt;doi:10.1080/10543406.2014.920873&amp;gt;, and the 3+3
described by Korn et al. (1994) &amp;lt;doi:10.1002/sim.4780131802&amp;gt;. All designs
are implemented with a common interface. We also offer optional additional
classes to tailor the behaviour of all designs, including avoiding skipping
doses, stopping after n patients have been treated at the recommended dose,
stopping when a toxicity condition is met, or demanding that n patients are
treated before stopping is allowed. By daisy-chaining together these classes
using the pipe operator from 'magrittr', it is simple to tailor the
behaviour of a dose-finding design so it behaves how the trialist wants.
Having provided a flexible interface for specifying designs, we then provide
functions to run simulations and calculate dose-paths for future cohorts of
patients."><meta property="og:image" content="/logo.png"></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>


    <nav class="navbar navbar-expand-lg fixed-top bg-light" data-bs-theme="light" aria-label="Site navigation"><div class="container">

    <a class="navbar-brand me-2" href="../index.html">escalation</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.2.3</small>


    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="active nav-item"><a class="nav-link" href="../reference/index.html">Reference</a></li>
<li class="nav-item dropdown">
  <button class="nav-link dropdown-toggle" type="button" id="dropdown-articles" data-bs-toggle="dropdown" aria-expanded="false" aria-haspopup="true">Articles</button>
  <ul class="dropdown-menu" aria-labelledby="dropdown-articles"><li><a class="dropdown-item" href="../articles/A100-DoseSelectors.html">Using escalation</a></li>
    <li><a class="dropdown-item" href="../articles/A205-CRM.html">CRM - Continual Reassessment Method</a></li>
    <li><a class="dropdown-item" href="../articles/A207-NBG.html">NBG - Neuenschwander, Branson &amp; Gsponer</a></li>
    <li><a class="dropdown-item" href="../articles/A210-TPI.html">TPI - Toxicity Probability Interval Design</a></li>
    <li><a class="dropdown-item" href="../articles/A220-mTPI.html">mTPI - Modified Toxicity Probability Interval Design</a></li>
    <li><a class="dropdown-item" href="../articles/A230-BOIN.html">BOIN - Bayesian Optimal Interval Design</a></li>
    <li><a class="dropdown-item" href="../articles/A280-TITE.html">TITE-CRM and TITE-NBG - Time-to-Event Designs</a></li>
    <li><a class="dropdown-item" href="../articles/A310-EfficacyToxicity.html">EffTox, Wages &amp; Tait, and BOIN12 - Efficacy &amp; Toxicity Designs</a></li>
    <li><a class="dropdown-item" href="../articles/A360-Combinations.html">BOIN-COMB - Treatment Combination Designs</a></li>
    <li><a class="dropdown-item" href="../articles/A600-DosePaths.html">Working with dose-paths</a></li>
    <li><a class="dropdown-item" href="../articles/A700-Simulation.html">Simulating dose-escalation trials</a></li>
    <li><a class="dropdown-item" href="../articles/A710-SimulationComparison.html">Comparing dose-escalation designs by simulation</a></li>
  </ul></li>
<li class="nav-item"><a class="nav-link" href="../news/index.html">Changelog</a></li>
      </ul><ul class="navbar-nav"><li class="nav-item"><form class="form-inline" role="search">
 <input class="form-control" type="search" name="search-input" id="search-input" autocomplete="off" aria-label="Search site" placeholder="Search for" data-search-index="../search.json"></form></li>
<li class="nav-item"><a class="external-link nav-link" href="https://github.com/brockk/escalation/" aria-label="GitHub"><span class="fa fab fa-github fa-lg"></span></a></li>
      </ul></div>


  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="../logo.png" class="logo" alt=""><h1>The 'escalation' package.</h1>
      <small class="dont-index">Source: <a href="https://github.com/brockk/escalation/blob/HEAD/R/escalation-package.R" class="external-link"><code>R/escalation-package.R</code></a></small>
      <div class="d-none name"><code>escalation-package.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>escalation provides methods for working with dose-finding clinical trials.
We provide implementations of many dose-finding clinical trial designs,
ncluding the continual reassessment method (CRM) by O'Quigley et al. (1990)
&lt;doi:10.2307/2531628&gt;, the toxicity probability interval (TPI) design by Ji
et al. (2007) &lt;doi:10.1177/1740774507079442&gt;, the modified TPI (mTPI) design
by Ji et al. (2010) &lt;doi:10.1177/1740774510382799&gt;, the Bayesian optimal
interval design (BOIN) by Liu &amp; Yuan (2015) &lt;doi:10.1111/rssc.12089&gt;, EffTox
by Thall &amp; Cook (2004) &lt;doi:10.1111/j.0006-341X.2004.00218.x&gt;; the design of
Wages &amp; Tait (2015) &lt;doi:10.1080/10543406.2014.920873&gt;, and the 3+3
described by Korn et al. (1994) &lt;doi:10.1002/sim.4780131802&gt;. All designs
are implemented with a common interface. We also offer optional additional
classes to tailor the behaviour of all designs, including avoiding skipping
doses, stopping after n patients have been treated at the recommended dose,
stopping when a toxicity condition is met, or demanding that n patients are
treated before stopping is allowed. By daisy-chaining together these classes
using the pipe operator from 'magrittr', it is simple to tailor the
behaviour of a dose-finding design so it behaves how the trialist wants.
Having provided a flexible interface for specifying designs, we then provide
functions to run simulations and calculate dose-paths for future cohorts of
patients.</p>
    </div>


    <div class="section level2">
    <h2 id="see-also">See also<a class="anchor" aria-label="anchor" href="#see-also"></a></h2>
    <div class="dont-index"><p>Useful links:</p><ul><li><p><a href="https://brockk.github.io/escalation/" class="external-link">https://brockk.github.io/escalation/</a></p></li>
<li><p><a href="https://github.com/brockk/escalation" class="external-link">https://github.com/brockk/escalation</a></p></li>
<li><p>Report bugs at <a href="https://github.com/brockk/escalation/issues" class="external-link">https://github.com/brockk/escalation/issues</a></p></li>
</ul></div>
    </div>
    <div class="section level2">
    <h2 id="author">Author<a class="anchor" aria-label="anchor" href="#author"></a></h2>
    <p><strong>Maintainer</strong>: Kristian Brock <a href="mailto:kristian.brock@gmail.com">kristian.brock@gmail.com</a> (<a href="https://orcid.org/0000-0002-3921-0166" class="external-link">ORCID</a>)</p>
<p>Authors:</p><ul><li><p>Daniel Slade (<a href="https://orcid.org/0000-0001-6063-1283" class="external-link">ORCID</a>)</p></li>
<li><p>Michael Sweeting (<a href="https://orcid.org/0000-0003-0980-8965" class="external-link">ORCID</a>)</p></li>
</ul><p>Other contributors:</p><ul><li><p>Conor Norris (<a href="https://orcid.org/0009-0009-8850-0811" class="external-link">ORCID</a>) [contributor]</p></li>
<li><p>Bharat Bhushan (<a href="https://orcid.org/0009-0001-5271-7113" class="external-link">ORCID</a>) [contributor]</p></li>
</ul></div>

  </main><aside class="col-md-3"><nav id="toc" aria-label="Table of contents"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p>Developed by Kristian Brock, Daniel Slade, Michael Sweeting.</p>
</div>

<div class="pkgdown-footer-right">
  <p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.1.3.</p>
</div>

    </footer></div>





  </body></html>

